XML 31 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
 6 Months Ended
Jul. 31, 2020
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
The fair value of the Company’s stock options and ESPP shares was estimated on the date of grant and the first day of the ESPP purchase period, respectively, using the Black-Scholes option pricing model. The weighted-average fair value per share for stock options grants, excluding assumed awards, was $48.50 and $40.06 in the three and six months ended July 31, 2020, respectively compared to $38.97 and $40.69 in the three and six months ended July 31, 2019, respectively. The weighted-average fair value per share for ESPP shares was $53.64 in the three months ended July 31, 2020 compared to $38.88 in the three months ended July 31, 2019.
Stock option activity, excluding the ESPP for the six months ended July 31, 2020 is as follows:
 Options Outstanding
 Outstanding
Stock
Options
(in millions)		Weighted-
Average
Exercise Price		Aggregate
Intrinsic Value (in millions)
Balance as of January 31, 202027 $98.56 
Options granted under all plans8 143.56 
Exercised(6)75.67 
Plan shares expired or canceled(1)136.90 
Balance as of July 31, 202028 $115.05 $2,183 
Vested or expected to vest25 $112.45 $2,073 
Exercisable as of July 31, 202011 $79.70 $1,312 
The following table summarizes information about stock options outstanding as of July 31, 2020:
 Options OutstandingOptions Exercisable
Range of Exercise
Prices		Number
Outstanding
(in millions)		Weighted-
Average
Remaining
Contractual Life
(Years)		Weighted-
Average
Exercise
Price		Number of
Shares
(in millions)		Weighted-
Average
Exercise
Price
$0.36 to $59.34
6 3.5$39.57 5 $40.99 
$59.64 to $80.99
4 3.476.55 3 77.67 
$81.88 to $118.04
4 4.5114.83 2 113.95 
$122.03 to $148.95
2 5.8142.35 0 0.00 
$154.14
6 6.7154.14 0 0.00 
$155.20 to $191.65
6 5.7163.49 1 161.50 
28 5.0$115.05 11 $79.70 
Restricted stock activity for the six months ended July 31, 2020 is as follows:
 Restricted Stock Outstanding
 Outstanding
(in millions)		Weighted-Average Grant Date Fair ValueAggregate
Intrinsic
Value (in millions)
Balance as of January 31, 202028 $140.14 
Granted - restricted stock units and awards11 158.87 
Granted - performance-based stock units1 154.14 
Canceled(1)139.50 
Vested and converted to shares(7)132.77 
Balance as of July 31, 202032 $148.39 $6,076 
Expected to vest27 $5,260 
During the six months ended July 31, 2020 the Company recognized stock-based expense related to its equity plans for employees and non-employee directors of $1.1 billion. The aggregate stock compensation remaining to be recognized as of July 31, 2020 is as follows (in millions):
Fiscal Period:
Remaining six months of fiscal 2021$1,115 
Fiscal 20221,759 
Fiscal 20231,273 
Fiscal 2024690 
Fiscal 2025114 
Total stock compensation$4,951 
The expected amortization reflects only outstanding stock awards as of July 31, 2020 and assumes no forfeiture activity. The aggregate stock compensation remaining to be recognized to costs and expenses will be recognized over a weighted-average period of approximately 2 years.
Shares reserved and available for future issuance as of July 31, 2020 and January 31, 2020 were 148 million shares and 133 million shares, respectively.